Sarina Tanimoto, MD, MBA, chief medical officer, ARS Pharma | Image Credit: ARS Pharma
Neffy (epinephrine nasal spray; ARS Pharma) is a potential needle-free option to treat type 1 allergic reactions, including anaphylaxis in adults and children weighing more than 66 lbs.1
ARS Pharmaceuticals recently announced topline data for repeat doses of neffy, compared to repeat doses of epinephrine intramuscular (IM) injections with and without nasal allergen challenge (NAC) conditions in response to the FDA's request of a pharmacokinetic (PK) and pharmacodynamic (PD) study issued in a September 2023 Complete Response Letter (CRL).1
Sarina Tanimoto, MD, MBA, chief medical officer, ARS Pharma, explains data from the study "Pediatric doses of neffy (intranasal nasal spray) demonstrate pharmacokinetic profiles that are equivalent to epinephrine injections products," in the Q+A interview below.
Data will be presented at the 2024 American Academy of Allergy, Asthma, & Immunology Annual Meeting (AAAAI) in Washington DC from February 23 to February 26, 2024.
Contemporary Pediatrics:
Can you explain how this study was organized, and what methods were used to compare pharmacokinetic profiles between neffy and epinephrine injection products?
Sarina Tanimoto, MD, MBA:
This study wasorganized asa single-arm, open-label [Pharmacokinetic-Pharmacodynamic] (PK/PD) study dosingneffy0.65 mg,1 mg or 2 mg (depending on subject weight) with PK/PD modeling to bridge to the data collected with injection in adults.A total of 80 total [individuals] were enrolled during the pediatric development of neffy. The 42 [individuals] presented in this AAAAI 2024 poster represents the data for the 2 doses (1 mg and 2 mg) dosed in the intended population for approval 1 mg for 15-30 kg [individuals], and 2 mg for 30 kg + [individuals].
[The] age of [participants] ranged from 4 years to 17 years old. Blood samples were collected over 120 minutes to determine how much epinephrine was absorbed after administration ofneffyand PD measures included blood pressure and heart rate which are directly impacted by epinephrine exposure.
The reason for the single-arm, open-label design was that FDA agreed it was not practical to conduct a randomized, crossover PK/PD study in children thatincluded injection as a comparator due to a variety of factors including the intense study conduct with respect to blood draws and duration, and general difficulty enrolling children wiling to be injected with epinephrine.FDA requested 10 [individuals] per dose group, but Europe requested 20 [individuals] per dose group, which is why this study has 21 [individuals] per dose group (for each 1 mg and 2 mg).
Separately from this EPI-10 study, to compare these data to injection, integrated PK analyses, including pharmacological base absorption model (PBAM) and a population pharmacokinetics assessments (POP PK) model werealsoused to extrapolate results from 0.3 mg IM injection and 0.3 mg EpiPen in our adult studies to pediatric subjects. These analyses demonstrated thatneffyachieved exposures in pediatrics that are comparable to or slightly greater than that observed withinjection inadults.
Contemporary Pediatrics:
Can you explain the make-up of the study?
Tanimoto:
EPI 10 included a total of 80 doses of neffy. Twelve [individuals] with body weight 15-30 kg received 0.65 mgneffyand 21 [individuals] with body weight 15-30 kg received 1 mgneffy. In the higher weight group of 30 kg or greater, 26 subjects received a 1 mg dose ofneffyand 21 subjects received a 2 mg dose ofneffy.
Thedata presented in this poster from the study included a total of 42 pediatric [individuals] that received the commercial doses ofneffywhich will be 1 mg for children 15 to <30 kg and 2 mg for children 30 kg or greater.
Half the [individuals] (n = 21) were 15-30 kg in weight, while the other half (n = 21) were 30kg+ in weight. Age range of subjects in the study is 4 to 17 years.
Contemporary Pediatrics:
Can you highlight the benefits of neffy compared to epinephrine injections, of course acknowledging there is no needle. What other benefits are there for neffy regarding the pediatric indication?
Tanimoto:
The literature indicates that parents are fearful and anxious to inject their own children with an epinephrine autoinjector, which causes them to hesitate and potentially allow an allergic reaction to progress to a more serious and potentially life-threatening event.
Parents also worry whether caretakers, guardians or teachers will be willing or know how to use the autoinjector device when the parent is not present given their complexity and risk of injury due to the needle. There are more than 3,500 accidental self-injections in the [United States] annually with epinephrine autoinjectors according to National Poison Center data.
Furthermore, pediatric patients are particularly fearful of being injected or self-injecting. There are very routinereports of pediatric patients resisting injection, and twisting and jerking, which led to lacerations and injuries due to the needle.
Neffy, as an alternative to injection, addresses all these concerns in pediatric patients by removing the fear and anxiety associated with the needle as neither children nor untrained adults can harm the child or themselves withneffy.
Autoinjectors are also large and bulky, which makes it less likely for children to carry the device; there is some social stigma that has been reported with carrying the device around, especially among adolescents. Literature indicates that only 45% of pediatric subjects carry one epinephrine autoinjector with them, and only 22% of pediatric subjects carry 2 devices, as recommended by treatment guidelines.2
Neffyis easy for children to carry as it is much smaller than autoinjectors, fitting in a pocket in a convenient carrying case that can fit 2 devices as guidelines recommend (since a second dose is required in ~10% of events) just like a wireless earbuds case.
Many pediatric patients and their caregivers do not correctly use their EpiPen and other autoinjector devices. In one published study, only 32% of pediatric subjects correctly demonstrated use of the epinephrine autoinjector.3 In another randomized controlled study, only 43% of mothers were able to use an epinephrine autoinjector after training.4
Neffyis also easier to use than an autoinjector as 100% of children were able to useneffy in formal human factors studies after training, and even 100% of adult lay people (e.g. third-party caregivers) who have no knowledge of anaphylaxis were able to useneffywithout any training. Therefore, both children and their caregivers may more easily be able to useneffyconfidently at the first sign of an allergic reaction without anxiety of fear, or risk of injury from the needle.
References:
1. Fitch, J. Neffy epinephrine nasal spray demonstrates positive data in repeat dosing study. Contemporary Pediatrics. February 21, 2024. Accessed February 23, 2024. https://www.contemporarypediatrics.com/view/neffy-epinephrine-nasal-spray-demonstrates-positive-data-repeat-dosing-study
2. Warren CM, Zaslavsky JM, Kan K, Spergel JM, Gupta RS. Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults.Ann Allergy Asthma Immunol. 2018;121(4):479-489.e2. doi:10.1016/j.anai.2018.06.010
3. Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians.Pediatrics. 2000;105(2):359-362. doi:10.1542/peds.105.2.359
4.UmasuntharT,ProcktorA,HodesM,SmithJG,GoreC,CoxHE,MarrsT, HannaH,PhillipsK,PintoC,TurnerPJ,WarnerJO,BoyleRJ.Patients' ability to treat anaphylaxis using adrenaline autoinjectors: a randomized controlled trial.Allergy2015;70:855863.
Read the original post:
Neffy pharmacokinetic profiles compared to epinephrine injections - Contemporary Pediatrics
- Sang Pediatrics: When to see the doctor for a fever - YourCentralValley.com - May 12th, 2024 [May 12th, 2024]
- Should You Put Sunscreen on Infants? Not Usually - FDA.gov - May 12th, 2024 [May 12th, 2024]
- Thousands of bike helmets to be distributed to Ohio children | 10tv.com - 10TV - May 12th, 2024 [May 12th, 2024]
- How to talk to your teenaged patient about pregnancy and contraception - Contemporary Pediatrics - May 12th, 2024 [May 12th, 2024]
- Adult RSV Shots Given to More Than 30 Babies by Mistake - Medpage Today - May 12th, 2024 [May 12th, 2024]
- Pediatric Health Care Teams Can Help Prevent Youth Suicide - The Pew Charitable Trusts - May 12th, 2024 [May 12th, 2024]
- Small patients, big discoveries | Penn Today - Penn Today - May 12th, 2024 [May 12th, 2024]
- HCPs can play an important role in addressing the US infant formula shortage - Contemporary Pediatrics - May 12th, 2024 [May 12th, 2024]
- East Wenatchee Doctor Awarded For Boosting Child Vaccinations - KPQ - May 12th, 2024 [May 12th, 2024]
- HPV vaccination coverage of US-children aged 9-17 years in 2022 - Contemporary Pediatrics - May 12th, 2024 [May 12th, 2024]
- Weekly review: Profound genetic deafness gene therapy, measles increases, and more - Contemporary Pediatrics - May 12th, 2024 [May 12th, 2024]
- Pediatric Telehealth Platform Market is expected to Expand at a Massive CAGR of 26.6% through 2030 - openPR - May 12th, 2024 [May 12th, 2024]
- DB-OTO improved hearing to normal in child with profound genetic deafness - Contemporary Pediatrics - May 12th, 2024 [May 12th, 2024]
- The IT strategy behind a groundbreaking new $2B pediatric hospital - Healthcare IT News - May 12th, 2024 [May 12th, 2024]
- Modest Changes in Kids' Developmental Scores Seen From Pandemic - Medpage Today - April 23rd, 2024 [April 23rd, 2024]
- This pediatrics subspecialty has the best work-life balance - MD Linx - April 23rd, 2024 [April 23rd, 2024]
- PM Pediatrics Cobble Hill closing Pediatric urgent care options in Brooklyn and lower Manhattan - Brooklyn Bridge Parents - April 23rd, 2024 [April 23rd, 2024]
- Bethesda Pediatrics awarded $18,000 grant by GIVE - Yahoo! Voices - April 23rd, 2024 [April 23rd, 2024]
- Nemours Children's Health, UCF Partner to Elevate the Quality of Healthcare for Florida's Children - UCF - April 23rd, 2024 [April 23rd, 2024]
- Pediatricians told to talk to patients and parents about climate. - Grist - April 23rd, 2024 [April 23rd, 2024]
- Getting a good night's rest is vital for neurodiverse children pediatric sleep experts explain why - The Conversation - April 23rd, 2024 [April 23rd, 2024]
- Tina Cheng Honored as Exceptional CMO - Research Horizons - Research Horizons - April 23rd, 2024 [April 23rd, 2024]
- Let's talk about childhood injury prevention | Hub - The Hub at Johns Hopkins - April 23rd, 2024 [April 23rd, 2024]
- More young people with depression, anxiety in Virginia | Headlines - InsideNoVa - April 23rd, 2024 [April 23rd, 2024]
- Pediatrics fundraising event at Altru helps children with critical needs - Grand Forks Herald - April 15th, 2024 [April 15th, 2024]
- Public perceptions of families affected by pediatric cancer and educational work in pediatric oncology | Pediatric ... - Nature.com - April 15th, 2024 [April 15th, 2024]
- The pediatrician, the resident, the strawberry monster, and the zebra - VUMC News - VUMC Reporter - April 15th, 2024 [April 15th, 2024]
- Receptor targeting to identify medications for pediatric mental health concerns - Contemporary Pediatrics - April 15th, 2024 [April 15th, 2024]
- Hypoglossal nerve stimulation offers hope for pediatric Down syndrome patients with OSA - News-Medical.Net - April 15th, 2024 [April 15th, 2024]
- Efforts to reduce wait times for developmental evaluations - Baylor College of Medicine | BCM - April 15th, 2024 [April 15th, 2024]
- Nasal oxidative stress mediating the effects of colder temperature exposure on pediatric asthma symptoms | Pediatric ... - Nature.com - April 15th, 2024 [April 15th, 2024]
- Week in review: A new dermatology case study, and a new treatment for severe asthma - Contemporary Pediatrics - April 15th, 2024 [April 15th, 2024]
- Chordae Tendinea Rupture and Pulmonary Valve Vegetation in Pediatric Endocarditis: A Rare Condition - Cureus - April 7th, 2024 [April 7th, 2024]
- Pruitt named director of academic pediatrics division Washington University School of Medicine in St. Louis - Washington University School of... - April 7th, 2024 [April 7th, 2024]
- Researchers Show Injury Prevention Program Reduces Injuries in Young Children | Newsroom - UNC Health and UNC School of Medicine - April 7th, 2024 [April 7th, 2024]
- Provident Healthcare Partners Advises SouthernMED Pediatrics and Sweetgrass Pediatrics in a Partnership with U.S. ... - PR Newswire - April 7th, 2024 [April 7th, 2024]
- Online child safety laws could help or hurt 2 pediatricians explain what's likely to work and what isn't - The Conversation - April 7th, 2024 [April 7th, 2024]
- Hundreds of blue pinwheels draw attention for the need of doctors who specialize in child abuse pediatrics - MyStateline.com - April 7th, 2024 [April 7th, 2024]
- Pediatricians can help teens quit vaping and using tobacco - Odessa American - April 7th, 2024 [April 7th, 2024]
- CUTTING-EDGE RESEARCH SHAPING CHILDREN'S HEALTH SHOWCASED AT THE PEDIATRIC ACADEMIC ... - PR Newswire - April 7th, 2024 [April 7th, 2024]
- New NIAID report on maternal COVID-19 vaccination offers direct evidence of protection for newborns - Contemporary Pediatrics - April 7th, 2024 [April 7th, 2024]
- Navigating Pediatric Diabetes: A Q&A With Leading Expert David Maahs, MD - Stanford Medicine Children's Health Blog - Stanford Children's Health - March 29th, 2024 [March 29th, 2024]
- Linaclotide Succeeds for Functional Constipation in Children | GI and Hepatology News - MDedge - March 29th, 2024 [March 29th, 2024]
- Testing and diagnoses capacity of 2009 influenza and COVID-19 pandemics - Contemporary Pediatrics - March 29th, 2024 [March 29th, 2024]
- Predicting Infection Risk in Childhood Cancer - News Center - Feinberg News Center - March 29th, 2024 [March 29th, 2024]
- Healing the divide: Advancing access to pediatric care - HealthLeaders Media - March 29th, 2024 [March 29th, 2024]
- McMaster Child Health Research Day charts the future of pediatric health - Brighter World - March 29th, 2024 [March 29th, 2024]
- This is serious: The results of a measles outbreak have harmful outcomes - Contemporary Pediatrics - March 29th, 2024 [March 29th, 2024]
- Unlocking the Power of Influenza Vaccines for Pediatric Population: A Narrative Review - Cureus - February 29th, 2024 [February 29th, 2024]
- Human Papillomavirus Vaccines - Immunizations - American Academy of Pediatrics - February 29th, 2024 [February 29th, 2024]
- The role of the pediatrician in school-based mental health services - Contemporary Pediatrics - February 29th, 2024 [February 29th, 2024]
- Reminder for IPRC Webinar Preventing Secondary Trauma and Practical Self Care for Pediatric Rehabilitation ... - RCPA - February 29th, 2024 [February 29th, 2024]
- PCORI Awards CYSHCNet Researchers $5.5 Million to Study Transitions for Children and Caregivers from Hospital-to ... - UNC Health and UNC School of... - February 29th, 2024 [February 29th, 2024]
- Viewpoint: Journal Pediatrics reneges on its commitment to print response to botched article claiming GMOs are ... - Genetic Literacy Project - February 29th, 2024 [February 29th, 2024]
- NYC medical school will go tuition-free thanks to $1 billion gift from former pediatrics professor - Anchorage Daily News - February 29th, 2024 [February 29th, 2024]
- Innovative New Pediatric Facility Helps Alleviate Patient Anxiety - Healthcare Construction and Operations News - February 29th, 2024 [February 29th, 2024]
- Most pediatricians aren't prepared to handle teen opioid use, study says - WCVB Boston - February 29th, 2024 [February 29th, 2024]
- As Medicaid Shrinks, Clinics for the Poor Are Trying to Survive - The New York Times - February 29th, 2024 [February 29th, 2024]
- Many children hospitalized with COVID continue to face challenges. - Baltimore Sun - February 29th, 2024 [February 29th, 2024]
- Exposure to neighborhood violence linked to unmet health needs and increased care utilization in children - News-Medical.Net - February 29th, 2024 [February 29th, 2024]
- OUtMATCH: Omalizumab Proves Utility in Multiple Food Allergies for Pediatric, Adult Patients - MD Magazine - February 29th, 2024 [February 29th, 2024]
- Clinician quiz: AAP clinical practice guideline for treatment of children with obesity - Contemporary Pediatrics - February 29th, 2024 [February 29th, 2024]
- Contributed: Shortcomings and opportunities for health equity in pediatrics - Mobihealth News - January 27th, 2024 [January 27th, 2024]
- Committed to physician education to enhance children's health - UChicago Medicine - January 27th, 2024 [January 27th, 2024]
- What's leading to youth sports burnout? American Academy of Pediatrics report says 70% of kids are dropping out by 13 - WLS-TV - January 27th, 2024 [January 27th, 2024]
- Washington University School of Medicine joins collaboration to improve pediatric heart disease care - News-Medical.Net - January 27th, 2024 [January 27th, 2024]
- How to Treat Coughs in Kids - Health Matters - January 27th, 2024 [January 27th, 2024]
- COVID-19 vaccination during pregnancy and offspring neurodevelopment - Contemporary Pediatrics - January 27th, 2024 [January 27th, 2024]
- Discontinuing contact precautions for pediatric patients with methicillin-resistant Staphylococcus aureus - Contemporary Pediatrics - January 27th, 2024 [January 27th, 2024]
- Viewpoint: American Academy of Pediatrics fiasco International Association for the Research on Cancer is the ... - Genetic Literacy Project - January 27th, 2024 [January 27th, 2024]
- Recent reports of measles in multiple states - Contemporary Pediatrics - January 27th, 2024 [January 27th, 2024]
- Expert shares advice for parents navigating pediatric influenza, COVID-19, and RSV this winter - Newswise - January 27th, 2024 [January 27th, 2024]
- Global Group of Researchers Release New Criteria for Diagnosing Pediatric Sepsis and Septic Shock - AboutLawsuits.com - January 27th, 2024 [January 27th, 2024]
- Recurrent Syncope Unveiling Pulmonary Hypertension Secondary to Pulmonary Artery Thrombi in a Pediatric Patient - Cureus - January 8th, 2024 [January 8th, 2024]
- ChatGPT bombs test on diagnosing kids' medical cases with 83% error rate - Ars Technica - January 8th, 2024 [January 8th, 2024]
- ChatGPT is terrible at diagnosing child medical cases, according to new study - Mashable - January 8th, 2024 [January 8th, 2024]
- The clinical takeaways of the RSV immunizations - Contemporary Pediatrics - January 8th, 2024 [January 8th, 2024]
- Missouri pediatricians provide eight parenting goals to start the new year strong - Kirksville Daily Express and Daily News - January 8th, 2024 [January 8th, 2024]
- Reviewing the 2023 RSV season and an outlook on 2024 - Contemporary Pediatrics - January 8th, 2024 [January 8th, 2024]
- Predictive Factors for Insulin Resistance in Pediatric Obesity: A Comprehensive Analysis - Physician's Weekly - December 31st, 2023 [December 31st, 2023]